| Status | Acronym | ISRCTN | EudraCT | NCT (clinicaltrials.gov) | DRKS |
|---|---|---|---|---|---|
| Active | MAK-5-50+ |
Assessment of Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age by a Multipathogen Antigen-Based Rapid Test-Kit (MAK-5-50+)
Purpose / Objectives
Primary Outcome
To determine RSV prevalence and infection rates in volunteers ≥50 years in Germany
Secondary Outcomes
- To assess the clinical and economic impact of RSV-related ARI infections in volunteers ≥50 years in Germany
- To determine ADV, influenza A and B virus, RSV and SARS-CoV-2 prevalence and
infection rates in volunteers ≥50 years in Germany
- To assess the clinical and economic impact of ADV, influenza A and B virus and SARSCoV-2 related ARI infections in volunteers ≥50 years in Germany
- To describe factors impacting morbidity and mortality within the cohort such as age,
sex, underlying diseases and vaccination status
Diagnosis
- acute respiratory viral infection (ARI)
Target population
Age
50-99
Inclusion criteria
- Registered VACCELERATE Volunteer
- Residence in Germany
- ≥50 years
- Computer, smartphone or tablet access
- Electronic informed consent
Exclusion criteria
- Limited capacity to give consent
- Unable to understand the significance and implications of own actions
- Restricted capacity to use MAK-5 test kit
Study design
- Single center
- Prospective
Intervention
no intervention
Documents (password protected)
Go to download area (no documents yet)
Responsibilities in overall study
(National) Coordinating Investigator
Univ.-Prof. Dr. med. Oliver A. Cornely